Merit Medical Systems, Inc.
NASDAQ:MMSIMedical - Instruments & Supplies
+$1.16 today
- Market cap
- $5.15B
- Beta
- 0.53
- P/E (TTM)
- 28.4
- EPS (TTM)
- $2.34
Volume 0.46M
Average 0.79M
MMSI EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Merit Medical Systems, Inc.NASDAQ: MMSI
EBITDA · Q3 FY2026 · quarter ended Sep 2026
EBITDA dips below year-ago levels
Q3 FY2026 EBITDA of $58.76M fell 26.1% year over year, behind the +9.0% change in trailing-twelve-month EBITDA. Sequentially, it fell 39.7% from the prior quarter. Over 3 fiscal years it compounded at +22.4% a year.
Context
- EBITDA amounted to 21.9% of revenue in FY2025, up 1.7 pp from a year earlier.
- EBITDA increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 9 analysts of $456.51M (+37.5%) for the fiscal year ending Dec 2026, a step up from the +21.2% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $58.76M-39.7% QoQ
- Last fiscal yearDec 2025
- $332.05M+21.2% YoY
- LTMSep 2026
- $341.34M+9.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -26.1% | +29.9% | +56.0 pp |
| 1 year | +21.2% | +37.5% | +16.3 pp |
| 3-year CAGR | +22.4% | +14.4% | -8.0 pp |
| 5-year CAGR | +9.1% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 332.05M USD
- Year-over-year change
- +21.2%
- 4-year CAGR
- +21.0%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 332.05M | +21.2% |
| FY2024 | 2024-12-31 | 273.97M | +19.7% |
| FY2023 | 2023-12-31 | 228.89M | +26.3% |
| FY2022 | 2022-12-31 | 181.17M | +16.9% |
| FY2021 | 2021-12-31 | 154.96M | — |
EBITDA vs competitors
How MMSI compares with its peers on the latest reported figures
- MMSI's LTM Sep 2026 EBITDA of $341.34M is the 4th highest of the 10 companies compared; the peer median is $169.63M.
- Its year-over-year change of +9.0% is the 5th highest of 10, against a peer median of -1.9%.
- EBITDA amounts to 21.2% of revenue for MMSI, versus a peer median of 12.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $5.8B | +23.2% | +23.0% | 27.6% | |
| LTM Sep 2026 | $4.74B | -1.9% | +1.5% | 23.4% | |
| LTM Jun 2026 | $2.47B | +93.4% | +3.9% | 29.7% | |
| LTM Sep 2026 | $341.34M | +9.0% | +22.4% | 21.2% | |
| LTM Jun 2026 | $247.61M | -23.3% | +17.3% | 11.5% | |
| LTM Mar 2026 | $169.63M | -31.6% | +170.6% | 12.4% | |
| LTM Mar 2026 | $96.3M | +31.7% | +35.0% | 37.6% | |
| LTM Jun 2026 | $37.73M | +508.5% | — | 6.6% | |
| LTM Feb 2026 | -$5.44M | -1089.6% | -46.2% | 1.7% | |
| LTM Jun 2026 | -$158.49M | -126.4% | -25.5% | 6.1% | |
| Peer median (excluding MMSI) | $169.63M | -1.9% | +10.6% | 12.4% | |
Competitors are the stored peer set for MMSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.07B | 1.15B | 1.26B | 1.36B | 1.51B |
| Cost of Revenue | 589.42M | 631.88M | 673.49M | 713.18M | 777.79M |
| Gross Profit | 485.33M | 519.1M | 583.87M | 643.33M | 736.94M |
| Gross Margin | 45.2% | 45.1% | 46.4% | 47.4% | 48.7% |
| Research & Development | 71.25M | 75.51M | 82.73M | 83.81M | 97.35M |
| Selling, General & Admin | 335.69M | 342.53M | 373.68M | 376.73M | 455.21M |
| Operating Expenses | 424.42M | 431.54M | 458.73M | 487.64M | 552.57M |
| Depreciation & Amortization | 95.78M | 92.2M | 101.29M | 114.73M | 134.65M |
| EBITDA | 154.96M | 181.17M | 228.89M | 273.97M | 332.05M |
| EBITDA Margin | 14.4% | 15.7% | 18.2% | 20.2% | 21.9% |
| Operating Income | 60.92M | 87.56M | 123.94M | 155.69M | 184.38M |
| Operating Margin | 5.7% | 7.6% | 9.9% | 11.5% | 12.2% |
| Interest Income | 769K | 439K | 2.46M | 26.23M | 15.07M |
| Interest Expense | 5.26M | 6.34M | 15.51M | 31.22M | 26.46M |
| Other Income / Expenses | (7M) | (4.93M) | (11.86M) | (5.7M) | (13.44M) |
| Income Before Tax | 53.92M | 82.63M | 112.09M | 149.99M | 170.94M |
| Pre-Tax Margin | 5.0% | 7.2% | 8.9% | 11.1% | 11.3% |
| Income Tax Expense | 5.46M | 8.11M | 17.68M | 29.64M | 42.45M |
| Net Income | 48.45M | 74.52M | 94.41M | 120.36M | 128.49M |
| Net Margin | 4.5% | 6.5% | 7.5% | 8.9% | 8.5% |
| EPS (Basic) | 0.86 | 1.31 | 1.64 | 2.07 | 2.17 |
| EPS (Diluted) | 0.84 | 1.29 | 1.62 | 2.03 | 2.13 |
| Weighted Avg Shares | 56.15M | 56.81M | 57.59M | 58.22M | 59.16M |
| Weighted Avg Shares (Diluted) | 57.36M | 57.67M | 58.36M | 59.37M | 60.46M |
Merit Medical Systems, Inc.
NASDAQ:MMSI
Intrinsic Alpha fair value
Locked
Current Price
$85.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.